PRIME MEMBER EXCLUSIVE | 3 Months Free Trial
Auto-renews at INR 199/mo after 3 months. Cancel anytime. Offer ends 15 July, 2026.
Healthcare India Podcast | Manipal IPO Explained
Failed to add items
Add to cart failed.
Add to wishlist failed.
Remove from wishlist failed.
Follow podcast failed
Unfollow podcast failed
Healthcare India Podcast | Manipal IPO Explained
-
Narrated by:
-
Written by:
The Manipal Health Enterprises IPO marks a shift in Indian healthcare—from expansion to efficiency.
In this episode, we break down what investors often miss:
This is not a turnaround or margin expansion play. Manipal is already operating at ~25–27% EBITDA margins and ~65–67% occupancy, with a ₹9,000 crore scale.
So what’s the real bet?
We explore:
Why this IPO is about sustaining excellence, not chasing growthThe true drivers of valuation: ARPOB, case mix, capital disciplineA realistic ₹45,000–₹60,000 crore valuation lensKey risks: doctor dependency, pricing pressure, integration complexity
If you’re looking beyond headlines to fundamentals, this episode will reframe the way you evaluate hospital IPOs.
This is not a bet on demand. It’s a bet on execution.